By Dr Sierra Jones, research science writer covering peptide chemistry and laboratory sourcing standards. Fact-checked by Editor Robbie Brown. 

GLOW and KLOW are research peptide blends that share three ingredients. GLOW contains BPC-157, TB-500, and GHK-Cu. KLOW contains those same three, plus a fourth peptide called KPV. If you’ve been flipping between those two products, trying to figure out what you’re comparing, this guide is for you.

The three shared peptides turn up in research on tissue repair, regeneration, collagen pathways, and cell signaling. KPV is studied for inflammatory signaling and antimicrobial activity, which the other three don’t address directly.

So GLOW is the simpler three-peptide option. KLOW keeps that same foundation and adds one more research angle. Below, we’ll cover what each peptide is studied for, what KPV adds in KLOW, and how to check a vial’s purity claims. For researchers, Kylo Peptides, with 99%+ purity confirmation on a lot-matched COA, forms the benchmark in 2026.

What Is the GLOW Blend and How Does It Work?

GLOW blend is a three-peptide research blend: GHK-Cu at 50mg, BPC-157 at 10mg, and TB-500 at 10mg, for 70mg total. Here’s what each one brings.

BPC-157

BPC-157 is a gastric pentadecapeptide, a 15-amino-acid sequence first identified in gastric juice. Researchers study it in relation to tissue-repair mechanisms, angiogenesis, and cellular signaling. It also appears in gastrointestinal work. Most of that literature sits in animal and cell-culture models.

TB-500

TB-500 is a synthetic fragment of thymosin beta-4, a natural protein found in the body. Research describes the full protein as the major G-actin-sequestering protein in mammalian cells, meaning it manages the internal scaffolding that lets cells change shape and migrate to a damaged site. The fragment is therefore being studied for cell migration, tissue remodeling, and wound healing.

GHK-Cu

GHK-Cu is a copper-bound tripeptide and, by weight, the biggest ingredient in both blends. Researchers study it in regenerative and skin-focused science, investigating links to collagen pathways and the extracellular matrix, the structural mesh that holds tissue together. According to Pickart and Margolina in the journal Cosmetics, GHK “stimulates or suppresses 31.2% of human genes with a change of 50% or more.

How the Three Components Work Together

The individual peptides act through different mechanisms researchers see as potentially complementary: BPC-157 around angiogenesis, TB-500 around cell migration, GHK-Cu around matrix and gene signaling. That’s the appeal of the blends. 

What Is the KLOW Blend and How Does It Work?

KLOW takes that same three-peptide foundation as GLOW and adds KPV. 

BPC-157 + TB-500 + GHK-Cu + KPV

The first three are at the same amounts as GLOW. Same peptides, same milligrams, same research roles. KPV is the only new addition, and it accounts for the extra 10 mg, bringing the total to 80 mg per KLOW vial.

What KPV Adds

KPV is a three-amino-acid sequence, Lys-Pro-Val, taken from the tail end of alpha-MSH, a hormone involved in pigmentation and inflammation signaling. It’s the shortest peptide in the blend.

Research interest around KPV points to inflammatory signaling, NF-kB-related pathways, cytokine signaling, antimicrobial activity, and intestinal barrier work.

How KLOW Differs From GLOW

KLOW adds 10mg KPV to the three compounds already in GLOW. So, the total moves to 80mg against GLOW’s 70mg, a 14.3% rise in peptide mass per vial.

GHK-Cu makes up 71.4% of a GLOW vial and 62.5% of a KLOW vial, while its absolute amount stays put at 50mg. KPV also adds its own uptake route, since published work describes it crossing cell membranes through the PepT1 transporter.

Why the Additional Peptide Matters

Adding KPV broadens the range of questions the blend can answer. GLOW covers repair and regeneration mechanisms. KLOW covers those and also opens the door to inflammatory and immune-signaling work.

GLOW vs KLOW Peptide Blend: Head-to-Head Comparison

GLOW is a 70mg three-peptide blend. KLOW is an 80mg four-peptide blend containing everything in GLOW plus 10mg of KPV. The shared peptides are present in identical amounts, while the new one adds an extra 10mg. 

What Makes KPV the Key Difference?

KPV is a tripeptide studied for its effect on inflammatory signaling pathways. It separates the two blends by research and mechanistic scope.

What Is KPV?

KPV stands for its three amino acids: lysine, proline, and valine. The sequence comes from the C-terminal end of alpha-MSH, the hormone mentioned earlier. Researchers have investigated it in inflammatory and immune-signaling models for well over a decade. 

KPV and NF-kB-Related Research

NF-kB is a transcription factor, basically a switch that turns inflammatory genes on. KPV has been investigated in relation to that switch.

The most-cited work is Dalmasso and colleagues in Gastroenterology, which reported that “nanomolar concentrations of KPV inhibit the activation of NF-kappaB and MAP kinase inflammatory signaling pathways, and reduce pro-inflammatory cytokine secretion.”

The same paper also reported that KPV enters cells through PepT1, a transporter that carries small peptides across cell membranes.

KPV and Cytokine Research

Cytokines are the signaling molecules cells use to coordinate an inflammatory response. KPV research has examined mediators including IL-1 beta, IL-6, and TNF-alpha. Those results come from cell cultures and mouse models. 

KPV and Antimicrobial Research

KPV is the tail end of a hormone called alpha-MSH, which sits in the gut and skin. Those are the places the body meets microbes first, so researchers tested whether KPV could slow them down. A 2000 study in the Journal of Leukocyte Biology reported it reducing growth of Staphylococcus aureus, a bacterium, and Candida albicans, a yeast, in lab tests. 

Why KPV Changes the GLOW vs KLOW Comparison

GLOW is a three-peptide foundation for repair and regeneration. KLOW is the same foundation with a KPV-driven inflammatory angle. 

Research Focus

When Should You Choose KLOW?

KLOW earns its place when the research model actually involves inflammation. If your protocol never investigated inflammatory signaling, the fourth peptide won’t help.

KPV is a relevant formulation to look at when the work involves:

• Inflammatory signaling pathways
• Gut-barrier or intestinal inflammation models
• Skin inflammation models
• Antimicrobial research questions
• Studies examining inflammation and tissue repair side by side

KLOW is broader than GLOW. The extra peptide makes it relevant to questions GLOW cannot address, simply because GLOW contains no KPV. 

When Should You Choose GLOW?

GLOW is the simpler formulation, and a real advantage when your research question is focused. Three components account for three variables, which makes your results easier to read and defend when someone asks how you got them.

It tends to be the more relevant pick when the objective centers on:

• Tissue-repair mechanisms
• Skin-related research
• Collagen and extracellular matrix work
• Cellular regeneration
• BPC-157 and TB-500 research
• GHK-Cu-related pathways

The right choice between GLOW vs KLOW depends entirely on what the research model is built to investigate.

Storage, Handling, and Purity Standards

Both blends are lyophilized powders and are handled the same way. To verify purity, access the testing documentation from an independent lab. 

Storage

Follow the supplier’s product-specific storage instructions. Lyophilized powders are generally frozen at minus 20 degrees Celsius, sealed against light and moisture, with minus 80 suited to longer holding. Once reconstituted, store the solution at 2 to 8 degrees.

Handling

Minimize exposure to heat and light. Follow standard contamination protocols during reconstitution, and avoid repeated freeze-thaw cycles.

Purity and Documentation

A batch-specific Certificate of Analysis is the baseline, covering identity testing, purity testing, HPLC results, mass spectrometry confirmation, and sterility or endotoxin testing where the work calls for it.

For a blend, ask one extra question: does the COA quantify each component separately, or report only a total? Kylo Peptides, for instance, supplies each peptide at 99% or higher purity by HPLC with identity confirmed by LC-MS, tested by 3 different accredited labs, and quantifies each component separately on a lot-matched COA. 

How Researchers Choose Between Them

To choose between GLOW and KLOW blend, run the same five checks every time. 

1. Define the Research Question

Ask whether the study is purely about repair and regeneration, or whether inflammation is part of what you’re measuring. That answer alone resolves most of this comparison.

2. Compare the Composition

Confirm whether your model requires KPV. If it doesn’t, you’re paying for a variable you won’t use.

3. Examine the Evidence

Look at the evidence for each peptide. Strong data on GHK-Cu stays with GHK-Cu, and treating it as proof for the whole blend is a common mistake.

4. Check Quality Documentation

Pull the COA and check it against the lot number of the vial in your hand. A generic document reused across batches tells you nothing about the material you received.

5. Consider Experimental Requirements

Storage capacity, reconstitution plans, and handling constraints feed into the final call, so factor them in before you order.

FAQ

Is KLOW the same as GLOW?

No. Both contain BPC-157, TB-500, and GHK-Cu, but KLOW also contains KPV. The shared peptides are in the same amounts, making KPV the only compositional difference.

What is the main difference between GLOW and KLOW? 

KPV. GLOW is a three-peptide blend at 70mg total. KLOW is those same three plus 10mg of KPV, bringing it to 80mg. Nothing gets removed or substituted.

Does GLOW contain KPV? 

No. GLOW contains only BPC-157, TB-500, and GHK-Cu. A page listing GLOW with KPV is either describing KLOW or has the composition wrong.

What does KPV add to KLOW? 

A research focus on inflammatory signaling, immune-related pathways, and antimicrobial activity. Those threads sit outside what the other three peptides are typically studied for.

Which is better, GLOW or KLOW? 

Neither is universally better. GLOW is simpler and suits focused repair work. KLOW is broader and suits models where inflammation is also measured. The research question decides it.

Is KLOW just GLOW with KPV? 

Compositionally, yes, and that’s the cleanest way to hold it in your head. KLOW uses the same three core peptides at the same amounts and adds KPV as a fourth.

Are GLOW and KLOW approved medications? 

No. Both are supplied strictly as research products. In July 2026, an FDA advisory committee voted 8 to 6, with one abstention, to recommend easing compounding restrictions on BPC-157, KPV, and TB-500, despite the agency’s own scientists’ advice. The FDA has yet to adopt it.

Should researchers look at individual peptide research? 

Yes. Assess evidence for a single compound separately from evidence for the full blend. Four peptides in one vial makes attributing a result to a specific component much harder.

Final Thoughts

GLOW and KLOW have the same three peptides, BPC-157, TB-500, and GHK-Cu, at the same amounts. KLOW adds one extra ingredient, KPV at 10mg. If inflammation is part of what you’re studying, choose the KLOW blend. If it stays outside your protocol, GLOW does the job with one fewer variable to control for.

When buying a vial for research, check the COA, the lot number, and that each component is quantified separately. Both blends are only as useful as the documentation standing behind them.

Disclaimer: KLOW and GLOW peptides are meant for research use only, not for human or veterinary consumption. This article covers composition, mechanism, and documentation. This is not medical advice, and none of the compounds discussed are FDA-approved medications.

Stay updated, free articles. Join our Telegram channel

Join